tweenvest

ABL Texcell Diagnostics SA (ENXTPA: ABLD)

Industria · Empresas comerciales y distribuidores · FR

2,40 €

+0,84 % hoy · -17,2 % 1 año

Ficha pública
Un resumen gratuito de ABL Texcell Diagnostics SA, con datos del 15 nov 2026. El análisis completo está en la app.Abrir en la app

ABL Texcell Diagnostics SA (ENXTPA: ABLD) opera en la industria de empresas comerciales y distribuidores dentro del sector industria. Su valor en bolsa es de 42,45 M $ y tiene 22 empleados.

En los últimos doce meses la acción ha bajado un 17,2 % y ha cotizado entre 2,10 y 5,00.

Tweenvest puntúa a ABL Texcell Diagnostics SA en cuatro factores: calidad 53/100, valor 60/100, dividendo 40/100. Su punto más fuerte es valor.

Evolución de la cotización de ABLD

21 nov 2025 · 2,80Cierres semanales 2,20 – 3,8416 nov 2026 · 2,40

Cifras clave

Capitalización
42,45 M $
Ingresos (últ. 12 m)
12,71 M $
PER
18,40
BPA
—
Rent. por dividendo
4,58 %
Beta (5 años)
-0,52
Máximo 52 semanas
5,00 €
Mínimo 52 semanas
2,10 €
Volumen medio (3 m)
—
Acciones en circulación
16,07 M
Empleados
22
Próximos resultados
—

Sobre ABL Texcell Diagnostics SA

ABL Texcell Diagnostics SA provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and internationally. The company offers genotyping through NGS and sanger sequencing for human immunodeficiency virus, SARS CoV-2, hepatitis-C virus, mycobacterium tuberculosis, and 16S/18S RNA, hepatitis-B Virus (HBV), cytomegalovirus (CMV), herpes simplex virus (HSV), BK virus (BKV), human papillomavirus (HPV), respiratory syncytial virus (RSV), and salmonella; real time PCR assays; ultragene assays for viral detection of SARS CoV-2, MonkeyPox, and Clostridium; microbiological specimen transport and collection kits, which include saliva preservation, wastewater collection, and surface collection kits, as well as inactivation and preservation solution; and instrument and consumables, such as DNA/RNA extraction system, real-time PCR system, liquid handling robot, next generation sequencing (NGS) library preparation kit, and sanger sequencing reaction. It also provides digital solutions comprising analysis software, data hosting, lab automation, Nadis, and SeqHepB. The company sells its products directly, as well as through a network of distributors to academic clinical pathology labs, private reference labs, and researchers. The company was formerly known as ABL Diagnostics Société anonyme and changed its name to ABL Texcell Diagnostics SA in April 2022. The company is headquartered in Woippy, France. ABL Texcell Diagnostics SA operates as a subsidiary of Advanced Biological Laboratories (ABL) S.A.

ISIN
FR001400AHX6
Cotiza desde
12 dic 2000
Bolsa
Euronext Paris
Divisa
EUR
EmpresaCapitalizaciónPrecioDía
Otake CorporationTSE: 743443,16 M $1747,00 ¥+1,16 %
Kimura Co.,Ltd.TSE: 746143,14 M $465,00 ¥+0,22 %
PT Berkah Prima Perkasa TbkIDX: BLUE42,75 M $1865,00 Rp-1,32 %
Yem Chio Distribution Co., Ltd.TPEX: 317142,57 M $51,80 NT$-0,77 %
Sin Heng Heavy Machinery LimitedSGX: BKA42,25 M $0,50 S$0,00 %
ProService Building Services Marketplace PlcAIM: PRO42,05 M $0,04 £-2,44 %
CSC Holdings LimitedSEHK: 23541,57 M $0,02 HK$-11,11 %
Kothari Products LimitedBSE: 53029940,67 M $64,24 Rs+4,56 %

Ver todas las empresas de empresas comerciales y distribuidores →